Sex and gender differences in HIV-1 infection

被引:70
作者
Griesbeck, Morgane [1 ]
Scully, Eileen [2 ]
Altfeld, Marcus [3 ]
机构
[1] Ctr Immunol & Infect Dis CIMI, F-75013 Paris, France
[2] Ragon Inst MGH MIT & Harvard, Cambridge 02139, MA USA
[3] Heinrich Pette Inst, D-20251 Hamburg, Germany
关键词
acquisition; oestrogen signalling; HIV-1; immune activation; sex; viral loads; HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; PLASMACYTOID DENDRITIC CELLS; ACTIVE ANTIRETROVIRAL THERAPY; HORMONAL CONTRACEPTIVE USE; DEPOT-MEDROXYPROGESTERONE ACETATE; LENTIVIRUS-INDUCED PROTECTION; GENITAL-TRACT INFLAMMATION; FEMALE REPRODUCTIVE-TRACT; ESTROGEN-RECEPTOR-ALPHA;
D O I
10.1042/CS20160112
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The major burden of the human immunodeficiency (HIV) type 1 pandemic is nowadays carried by women from sub-Saharan Africa. Differences in the manifestations of HIV-1 infection between women and men have been long reported, and might be due to both socio-economic (gender) and biological (sex) factors. Several studies have shown that women are more susceptible to HIV-1 acquisition than men. Following HIV-1 infection, women have lower viral loads during acute infection and exhibit stronger antiviral responses than men, which may contribute to differences in the size of viral reservoirs. Oestrogen receptor signalling could represent an important mediator of sex differences in HIV-1 reservoir size and may represent a potential therapeutic target. Furthermore, immune activation, a hallmark of HIV-1 infection, is generally higher in women than in men and could be a central mechanism in the sex difference observed in the speed of HIV-1 disease progression. Here, we review the literature regarding sex-based differences in HIV-1 infection and discuss how a better understanding of the underlying mechanisms could improve preventive and therapeutic strategies.
引用
收藏
页码:1435 / 1451
页数:17
相关论文
共 194 条
[1]   Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of Depo-Provera before intravaginal challenge with simian immunodeficiency virus mac239 [J].
Abel, K ;
Rourke, T ;
Lu, D ;
Bost, K ;
McChesney, MB ;
Miller, CJ .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1697-1705
[2]   Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract [J].
Anahtar, Melis N. ;
Byme, Elizabeth H. ;
Doherty, Kathleen E. ;
Bowman, Brittany A. ;
Yamamoto, Hidemi S. ;
Soumillon, Magali ;
Padavattan, Nikita ;
Ismail, Nasreen ;
Moodley, Amber ;
Sabatini, Mary E. ;
Ghebremichael, Musie S. ;
Nusbaum, Chad ;
Huttenhower, Curtis ;
Virgin, Herbert W. ;
Ndung'u, Thumbi ;
Dong, Krista L. ;
Walker, Bruce D. ;
Fichorova, Raina N. ;
Kwon, Douglas S. .
IMMUNITY, 2015, 42 (05) :965-976
[3]  
Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218
[4]  
[Anonymous], 2012, HORM CONTR HIV TECHN
[5]  
[Anonymous], JAIDS J ACQ IMM DEF
[6]  
[Anonymous], MORTAL WKLY REP
[7]  
[Anonymous], GLOB SUMM AIDS EP 20
[8]  
[Anonymous], INT AIDS SOC 2015
[9]   Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells [J].
Arnold, Kelly B. ;
Burgener, Adam ;
Birse, Kenzie ;
Romas, Laura ;
Dunphy, Laura J. ;
Shahabi, Kamnoosh ;
Abou, Max ;
Westmacott, Garrett R. ;
McCorrister, Stuart ;
Kwatampora, Jessie ;
Nyanga, Billy ;
Kimani, Joshua ;
Masson, Lindi ;
Liebenberg, Lenine J. ;
Karim, Salim S. Abdool ;
Passmore, Jo-Ann S. ;
Lauffenburger, Douglas A. ;
Kaul, Rupert ;
McKinnon, Lyle R. .
MUCOSAL IMMUNOLOGY, 2016, 9 (01) :194-205
[10]   Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies [J].
Atashili, Julius ;
Poole, Charles ;
Ndumbe, Peter M. ;
Adimora, Adaora A. ;
Smith, Jennifer S. .
AIDS, 2008, 22 (12) :1493-1501